Abstract:Classical swine fever virus (CSFV) is a major animal pathogen threatening the global pork industry. To date, numerous anti-CSFV monoclonal antibodies (mAbs) and their recognizing epitopes have been reported. However, few mAbs were systematically characterized for the capacity to differentiate field CSFV isolates from CSF vaccine strains, and the molecular basis associated with antigenic differences between vaccines and field isolates is still largely unknown. In the present study, recombinant CSFV structural glycoproteins E2 of both virulent and vaccine strains and E rns of vaccine strain were expressed using eukaryotic cells and murine mAbs generated against E2 and E rns . After serial screening and cloning of the hybridomas, the viral spectra of mAbs were respectively determined by indirect fluorescent antibody assay (IFA) using 108 CSFVs, followed by Western blot analysis using expressed glycoproteins of all CSFV sub-genotypes including vaccine strains. The antigenic structures recognized by these mAbs were characterized by epitope mapping using truncated, chimeric, and site-directed mutated E2 and E rns proteins. We have identified two vaccine-specific, one field isolate-specific, and two universal CSFV-specific mAbs and five novel conformational epitopes with critical amino acid (aa) motifs that are associated with these five mAbs: 213 EPD 215 , 271 RXGP 274 , and 37 LXLNDG 42 on E2 and 38 CKGVP 42 , W 81 , and D 100 /V 107 on E rns . Particularly, E 213 of E2 is field isolate-specific, while N 40 of E2 and D 100 /V 107 of E rns are vaccine strain-specific. Results from our study further indicate that N 40 D of E2 mutation in field strains was likely produced under positive selection associated with long-term mass vaccination, leading to CSFV evasion of host immune response. Taking together, this study provides new insights into the antigenic structure of CSFV E2 and E rns and the differentiating mAbs will contribute to the development of a diagnostic strategy to differentiate C-strain vaccination from natural infection (DIVA) of CSFV in terms of elimination of CSF in China.

Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus.

The Epitope Recognized by Monoclonal Antibody 2B6 in the B/C Domains of Classical Swine Fever Virus Glycoprotein E2 Affects Viral Binding to Hyperimmune Sera and Replication.

Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.

Candidate Peptide-Vaccine Induced Potent Protection Against Csfv and Identified A Principal Sequential Neutralizing Determinant on E2

Hypervariable Antigenic Region 1 of Classical Swine Fever Virus E2 Protein Impacts Antibody Neutralization.

Candidate Vaccine Focused on a Classical Swine Fever Virus Epitope Induced Antibodies with Neutralizing Activity.

A novel linear epitope at the C-terminal region of the classical swine fever virus E2 protein elicits neutralizing activity

The Protective Immune Response Induced by B Cell Epitope of Classical Swine Fever Virus Glycoprotein E2

Preliminary Evaluation of a Candidate Multi-Epitope-Vaccine Against the Classical Swine Fever Virus

Characterization of Antibody Responses Against a Neutralizing Epitope on the Glycoprotein E2 of Classical Swine Fever Virus

Identification of neutralizing epitopes on the D/A domain of the E2 glycoprotein of classical swine fever virus

Multiple Linear B-cell Epitopes of Classical Swine Fever Virus Glycoprotein E2 Expressed in E.coli As Multiple Epitope Vaccine Induces a Protective Immune Response

jmbReview The Epitope Recognized by Monoclonal Antibody 2 B 6 in the B / C Domains of Classical Swine Fever Virus Glycoprotein E 2 Affects Viral Binding to Hyperimmune Sera and Replication

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Identification of E2 Strain with Improved Secretion and Immunogenicity Against CSFV in Piglets

Generation and epitope mapping of novel neutralizing monoclonal antibodies against glycoprotein E2 of CSFV

Broad neutralization of CSFV with novel monoclonal antibodies in vivo

Candidate Peptide Vaccine Induced Protection Against Classical Swine Fever Virus

Expression and immunogenicity of capsid protein of porcine circovirus type 2 with N-terminal chimeric neutralizing epitopes of foot-and-mouth disease virus

Characterization of monoclonal antibodies that specifically differentiate field isolates from vaccine strains of classical swine fever virus

Genetic Diversity of the Envelope Glycoprotein E2 of Classical Swine Fever Virus: Recent Isolates Branched Away from Historical and Vaccine Strains.